Erie County, NY Department of Health » ERIE COUNTY DEPARTMENT OF HEALTH TO PAUSE DISTRIBUTION OF JOHNSON & JOHNSON COVID-19 VACCINE

ERIE COUNTY DEPARTMENT OF HEALTH TO PAUSE DISTRIBUTION OF JOHNSON & JOHNSON COVID-19 VACCINE

Modified: April 13, 2021 9:34am

Latest News

Redirecting to our new, updated website ...
04/13/2021

ERIE COUNTY DEPARTMENT OF HEALTH TO PAUSE DISTRIBUTION OF JOHNSON & JOHNSON COVID-19 VACCINE

Decision made out of an abundance of caution, and based on recommendations by CDC, FDA and NYSDOH

ERIE COUNTY, NY – The Erie County Department of Health (ECDOH) will pause distribution of the Johnson & Johnson (Janssen) COVID-19 vaccine following a joint recommendation from the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the New York State Department of Health (NYSDOH).

A statement issued by the CDC and FDA today, April 13, recommended pausing the use of Johnson & Johnson COVID-19 vaccine. This followed reports of six cases of a “rare and severe” adverse events involving blood clots. Anyone who received Johnson & Johnson COVID-19 vaccine and develops symptoms of severe headache, stomach or abdominal pain, leg pain or shortness of breath within three weeks of their vaccination should contact their health care provider. The CDC and FDA statement noted that symptoms in those cases occurred between 6 and 13 days after vaccination.

ECDOH does not have any PODs (points of distribution) scheduled with Johnson & Johnson COVID-19 vaccine. ECDOH PODs planned for this week will administer Moderna vaccine, which is a two-dose series.

ECDOH has received a very limited quantity of Johnson & Johnson COVID-19 vaccine, which is a one-dose course. This supply was primarily used for vaccinating homebound and home-limited Erie County residents and individuals in congregate living settings. Any additional Johnson & Johnson COVID-19 vaccine administration to any Erie County resident has been placed on pause until further guidance is available.

The CDC and FDA are reviewing available data as part of their ongoing assessment for the safety and effectiveness of COVID-19 vaccines. ECDOH is closely monitoring the situation and will provide more information as it is available.

#

###